METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE Russian patent published in 2015 - IPC A61H9/00 A61H33/14 A61N5/67 

FIELD: medicine.

SUBSTANCE: what is used is a complex of three physical body exposures. That is ensured by an artificial circulatory support enabled by an enhanced external counterpulsation apparatus with a cuff pressure of 220 mm Hg as a one-hour session, once a day; the therapeutic course is 14-15 sessions. Herewith, during 10 sessions, one hour after the external counterpulsation, the patient takes carbon dioxide baths in the Reabox system at a carbon dioxide flow rate of 12 l/min, a gas mixture temperature of 36-37°C for 10-15 minutes. An infrared laser therapy is conducted 30 minutes after the bath, by using the Mustang 2000+ apparatus according to a stable technique with a 5 W emitter covering the apex of the heart, a middle one-third of the sternum, the left infrascapular region, 2-3 min. each. The laser therapy course includes 10 daily procedures.

EFFECT: providing higher clinical effectiveness by reducing the length of treatment and maintaining the achieved effects for a long period of time, preventing the disease progression, making it possible to use the method for all functional classes of IHD and all lengths of the disease, with achieving anti-ischemic, antianginal effect, improving myocardial contractility with saving cardiac activity, increasing exercise tolerance, myocardial and coronary reserves.

2 ex